Helicobacter pylori eradication reduced the risk for ulcers in dyspeptic patients who were about to begin NSAID treatment

van Zanten, Sander J.O. Veldhuyzen
July 2002
ACP Journal Club;Jul/Aug2002, Vol. 137 Issue 1, p13
Academic Journal
Provides information on a study that explored whether the eradication of Helicobacter pylori infection reduce the risk for ulcers in patients who have H. pylori and dyspepsia or a history of ulcer and who are about to begin nonsteroidal anti-inflammatory drug treatment. Study design and setting; Main outcome measures; Main results; Conclusion.


Related Articles

  • ERADICATE THE BUG BEFORE YOU START THE DRUG? Metz, David C.; Johnson, David // American Journal of Gastroenterology;Feb1998, Vol. 93 Issue 2, p279 

    Presents a commentary about a randomized trial of eradication of Helicobacter pylori before nonsteroidal anti-inflammatory drug (NSAID) therapy to prevent peptic ulcers. Evaluation and treatment of patients with nonulcer dyspepsia; Controversy regarding strategies for primary prevention of...

  • Low-risk criteria for dyspepsia under age 45.  // Journal of Family Practice;Jul2006, Vol. 55 Issue 7, p568 

    The article discusses the endoscopic evaluation of dyspepsia in patients between the ages of 18 and 45 years. The patients in this study had an average age of 35 years and were then divided into three groups based on their risk factors and symptoms. Group A were nonsteroidal anti-inflammatory...

  • Treatment of Peptic Ulcer Disease and Nonulcer Dyspepsia. Meurer, Linda N. // Journal of Family Practice;Jul2001, Vol. 50 Issue 7, p614 

    The article explains the treatment of peptic ulcer disease and nonulcer dyspepsia (NUD). It notes that the pathophysiology of nonulcer dyspepsia is not definitively known though factors implicated include gastric acid secretion, gastro-duodenal dysmotility, visceral hypersensitivity, stress and...

  • Helicobacter pylori infection common in ulcer patients.  // Cortlandt Forum;02/25/99, Vol. 12 Issue 2, p15 

    Informs that chronic Helicobacter pylori infection has been increasingly associated with gastric and duodenal ulcers unrelated to nonsteroidal anti-inflammatory drugs (NSAID). Role of H. pylori infection in the pathogenesis of nonulcer dyspepsia, particularly in users of NSAID.

  • Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Approaching the end of the controversy in the new millennium, or room for more debate? Leong, Rupert W. L.; Chan, Francis K. L.; Sung, Joseph J. Y. // Journal of Gastroenterology;2001, Vol. 36 Issue 11, p731 

    Examines the risk factors posed by Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAID) in the pathogenesis of gastrointestinal tract ulcers. Damages of the mucosa from Helicobacter pylori and NSAID; Effect of NSAID on Helicobacter pylori eradication.

  • Has the Impact of Helicobacter pylori Therapy on Ulcer Recurrence in the United States Been Overstated? Laine, Loren; Hopkins, Robert J.; Girardi, Luigi S. // American Journal of Gastroenterology;Sep1998, Vol. 93 Issue 9, p1409 

    Objective: The aim of this study was to assess the effect of H. pylori eradication on ulcer recurrence in North American duodenal ulcer patients by examining only treatment studies that met rigorous methodologic criteria. Methods: Data sources were computerized bibliographic searches...

  • Use of NSAIDs and infection with Helicobacter pylori–what does the rheumatologist need to know? Kiltz, U.; Zochling, J.; Schmidt, W. E.; Braun, J. // Rheumatology;Sep2008, Vol. 47 Issue 9, p1342 

    Objectives. NSAID-induced gastroduodenal lesions are a frequent and potentially serious health problem in patients with rheumatic diseases. Helicobacter pylori (H. pylori) has also been recognized as a major risk factor for the development of ulcer disease. However, the role of H. pylori in the...

  • Serologic testing is more cost-effective strategy for ulcer symptoms.  // Geriatrics;Oct95, Vol. 50 Issue 10, p16 

    Reports that antibiotic therapy following a positive serology for Helicobacter pylori appears to be the most cost-effective approach in treating patients with symptoms of peptic ulcers. Non-application of the strategy to treating peptic ulcer symptoms caused by chronic use of non-steroidal...

  • DEBUGging Your Ulcer RISK. M.A.D. // Arthritis Today;Mar/Apr2003, Vol. 17 Issue 2, p36 

    Discusses the link between the Helicobacter pylori bacterium and the risk of stomach ulcers associated with nonsteroidal anti-inflammatory drugs (NSAID). Factors that increase the risk of NSAID-induced ulcers.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics